[Exercise echocardiography to differentiate dilated cardiomyopathy from ischemic left ventricular dysfunction]. 2003

Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
Servicio de Cardiología Hospital Juan Canalejo, A Coruña, Spain. jpeteiro@mundo-r.com

OBJECTIVE Previous studies have shown the usefulness of dobutamine echocardiography to differentiate dilated cardiomyopathy (DC) from ischemic left ventricular dysfunction (ILVD), but no studies have been made using exercise echocardiography (EE). We hypothesized that most patients with DC have some contractile reserve and experience an increase in left ventricular ejection fraction (LVEF) during exercise, as opposed to patients with ILVD. Differences in response to EE may be useful to clinically differentiate between these two entities. METHODS Between 1 March 1995 and 1 March 2001, we performed 4,133 EE studies on 3,830 patients. Of 289 patients (8%) with moderate or severe LV dysfunction (biplane LVEF < 41% and left ventricular end-diastolic diameter > 5.2 cm), 207 were excluded: 111 for a history of myocardial infarction; 28 for scarring on echocardiography (regional akinesia/dyskinesia with thinning and/or increased brightness); 13 for previous revascularization procedures; 9 for aortic valve disease; 11 for a known cause of cardiomyopathy; and 35 for not undergoing angiography. The study group was therefore composed of 82 patients who were encouraged to perform maximal treadmill EE. EE criteria for ILVD were either impaired regional wall motion (RWM) or a decrease/no change in LVEF from baseline to peak exercise, while criteria for DC were RWM improvement/no change and LVEF increase. The ILVD group was formed by 39 patients with stenosis >/= 70% diameter stenosis of a major epicardial coronary artery or major branch vessel. The remaining 43 patients constituted the DC group. RESULTS The number of coronary risk factors (ILVD 2.0 1.1; DC 1.9 1.1), baseline LVEF (ILVD 30 7; DC 30 8), and exercise-induced angina (ILVD 23%; DC 14%) did not differ between groups (p = NS). ILVD patients achieved less Mets (6.6 3.1 vs 8.3 2.8; p < 0.05), had a lower heart rate x systolic blood pressure product (22 5 vs 27 7; p < 0.001), and developed regional and/or global LV dysfunction more frequently (79 vs 28%; p < 0.001). Sensitivity, specificity, positive and negative predictive values and global accuracy for ILVD detection were 79% (95% CI: 70-88), 72% (95% CI: 63-81), 72% (95% CI: 63-81), 79% (95% CI: 67-85), and 76% (95% CI: 69-83), respectively. CONCLUSIONS Global and/or regional LV function impairment with exercise is accurate in identifying patients with ILVD. This method could reduce the need for invasive procedures.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
July 2023, The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
September 1982, Journal of cardiography,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
September 1998, Heart (British Cardiac Society),
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
September 1989, Journal of cardiology,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
February 2005, The Annals of thoracic surgery,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
January 2003, Critical care nursing quarterly,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
May 1992, Journal of the American College of Cardiology,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
January 1991, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
January 1999, The American journal of cardiology,
Jesús Peteiro Vázquez, and Lorenzo Monserrat Iglesias, and Eugenia Vázquez Rey, and Ramón Calviño Santos, and Jose M Vázquez Rodríguez, and Ramón Fabregas Casal, and Jorge Salgado Fernández, and Jose A Rodríguez-Fernández, and Alfonso Castro Beiras
July 2024, International journal of cardiology,
Copied contents to your clipboard!